Insulin therapy is a lifesaving necessity for people with type 1 diabetes, and its essentially the only medication approved for managing the condition. But a variety of additional blood-sugar-lowering ...

According to the American Diabetes Association, more than 34 million Americans live with diabetes. On average, the cost of medical expenses for people with diagnosed diabetes is approximately 2.3 ...

CHICAGO (Reuters) - Walmart said on Tuesday that it will start selling private-label analog insulin this week at a deep discount to branded insulin vials and pens, as it seeks to drive growth at its ...

After nearly seven months and two prior recalls, Viatris continues to be vexed by labeling issues on its biosimilar to Sanofi’s diabetes blockbuster Lantus. Viatris’ Mylan this week said it was once ...

Problems cropped up in January when Mylan yanked one lot of non-interchangeable Semglee over fears of absent labels on certain prefilled pens. (syahrir maulana/iStock/Getty Images Plus) Viatris and ...

In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...

Tandem Diabetes Care (TNDM) stock is in focus as the EU grants CE mark expanding the indications for its automated insulin delivery systems. Read more here.

Credit: Getty Images. The recall does not pertain to the interchangeable biosimilars, Semglee (insulin glargine-yfgn) injection, or Insulin Glargine (insulin glargine-yfgn) injection. Mylan ...

Add Yahoo as a preferred source to see more of our stories on Google. When a clinician prescribes a medication for a purpose for which its not indicated by the U.S. Food and Drug Administration (FDA), ...